1 Key results: Average weight loss: -14.9% of body weight (vs -2.4% with placebo) 86.4% achieved at least 5% weight loss 69.1% achieved at least 10% weight loss 50.5% achieved at least 15% weight loss Wegovy 7.2 mg: the STEP UP trial The STEP UP trial compared semaglutide 7.2 mg with the standard 2.4 mg dose in adults with obesity over 72 weeks
"I was flying in more ways than one, and boy did I enjoy it." The results seem more compelling than your typical diet, which often starts well but then your depleted fat stores signal to the brain to seek food
Always consult a qualified healthcare provider before changing your medication, diet, supplements, or exercise routine especially when using GLP-1 medications such as Ozempic, Wegovy, or Mounjaro
It is typically mild to moderate, dose-dependent, and tends to resolve within the first few weeks at each dose level during titration
Sanjay Gupta invites neurologist Alexander Mauskop, author of "The End of Migraines" to explain how migraines start and how to stop them